Chuiyong Pak

Chuiyong Pak

Auto-generated profile, based on publicly available information

Chuiyong Pak

Division of Pulmonology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
TJTae Heum Jeong
Tae Heum Jeong
CPChuiyong Pak
Chuiyong Pak
MOMinsu Ock
Minsu Ock
SLSeock-Hwan Lee
Seock-Hwan Lee
JSJoung Sik Son
Joung Sik Son
YJYoung-Jee Jeon
Young-Jee Jeon
Jeong TH, et al. J Korean Med Sci. 2020 Aug;35(37):e333. https://doi.org/10.3346/jkms.2020.35.e333

1 November 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
CPChuiyong Pak
Chuiyong Pak
CCClayton T. Cowl
Clayton T. Cowl
JKJin Hyoung Kim
Jin Hyoung Kim
BKByung Ju Kang
Byung Ju Kang
TLTaehoon Lee
Taehoon Lee
YKYangho Kim
Yangho Kim
Pak C, et al. J Korean Med Sci. 2022 Nov;37(44):e319. https://doi.org/10.3346/jkms.2022.37.e319

1 October 2021 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
CPChuiyong Pak
Chuiyong Pak
WJWoori Jo
Woori Jo
JKJin Hyoung Kim
Jin Hyoung Kim
JIJae Uk Im
Jae Uk Im
JJJoseph Jeong
Joseph Jeong
SRSeung-Won Ra
Seung-Won Ra
Background: The association of invasive tracheobronchial aspergillosis (ITBA) with invasive pulmonary aspergillosis (IPA) is not well established. We aimed to compare clinical characteristics between patients who exhibited ITBA with IPA and those who exhibited isolated ITBA (iITBA). Additionally, the usefulness of serum or bronchial galactomannan (GM) tests in diagnosing ITBA was evaluated.Methods: This retrospective single-center case-control study was conducted over a period of 4 years. Fifteen patients were enrolled after confirming the presence of ITBA using bronchoscopy-guided biopsy (iITBA, 7 vs. ITBA+IPA, 8). Clinical characteristics of patients and results obtained from serum or bronchial GM tests were compared between the two groups. Mortality was assessed using data collected from a 6-month follow-up period.Results: The ITBA+IPA group showed a higher prevalence of hematologic malignancy (75% vs. 14%, p=0.029), a greater number of patients with multiple bronchial ulcers (75% vs. 14%, p=0.029), lower platelet counts (63,000/μL vs. 229,000/μL, p<0.001), and a mortality rate which was significantly higher (63% vs. 0%, p=0.026) than the iITBA group. In the ITBA+IPA group, 57% of patients tested positive according to the serum GM assay, whereas in the iITBA group, all patients tested negative (p=0.070). The bronchial GM level was high in both groups, but there was no significant difference between them.Conclusion: Patients with ITBA+IPA had a greater number of hematologic malignancies with lower platelet counts and a poorer prognosis than patients diagnosed with iITBA. Findings obtained from bronchoscopy and bronchial GM tests were more useful in diagnosing ITBA than the serum GM test results.